Paul Y. Song serves as Executive at NKGen Biotech, Inc., where they oversee executive responsibilities. Since joining the company, Paul Y. Song has executed 8 insider transactions totaling $2.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 7, 2023 involved purchasing 76.06 shares valued at $250.
Paul Y. Song currently holds 171,120.58 shares of NKGen Biotech, Inc. (NKGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Y. Song has been a net buyer of NKGN stock. They have purchased $2.5K and sold $0 worth of shares.
Paul Y. Song's most recent insider trade was on Dec 7, 2023, when they purchased 76.06 shares at $3.29 per share.
Get notified when new Form 4 filings are submitted
| $3.32 |
| Discretionary |
| Dec 5, 2023 | NKGN | $350 | Purchase | 105.17 | $3.33 | Discretionary |
| Dec 4, 2023 | NKGN | $500 | Purchase | 162.78 | $3.07 | Discretionary |
| Nov 27, 2023 | NKGN | $300 | Purchase | 103.25 | $2.91 | Discretionary |
| Nov 27, 2023 | NKGN | $400 | Purchase | 140.4 | $2.85 | Discretionary |
| Nov 22, 2023 | NKGN | $150 | Purchase | 52.63 | $2.85 | Discretionary |
| Nov 21, 2023 | NKGN | $280 | Purchase | 100 | $2.80 | Discretionary |